ストックスクリーナーアプリを入手
0.7748
0.92%
-0.0072
アフターアワーズ：
.79
0.0152
+1.96%
前日終値:
$0.782
開ける：
$0.7674
24時間の取引高:
60,203
Relative Volume:
0.11
時価総額：
$19.28M
収益：
$522.00K
当期純損益:
$-10.80M
株価収益率:
-1.3489
EPS:
-0.5744
ネットキャッシュフロー:
$-8.78M
1週間 パフォーマンス:
+4.00%
1か月 パフォーマンス:
+11.32%
6か月 パフォーマンス:
-49.36%
1年 パフォーマンス:
-57.43%
1日の値動き範囲:
$0.7525
$0.7976
1週間の範囲:
$0.6997
$0.82
52週間の値動き範囲:
$0.46
$1.87
Lexaria Bioscience Corp Stock (LEXX) Company Profile
名前
Lexaria Bioscience Corp
セクター
電話
250-765-6424
住所
100 - 740 MCCURDY ROAD, KELOWNA
Compare LEXX vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
0.7748 | 19.46M | 522.00K | -10.80M | -8.78M | -0.5744 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Lexaria Bioscience Corp (LEXX) 最新ニュース
FOMO Trade: How does Lexaria Bioscience Corp correlate with Nasdaq2026 Momentum Check & Consistent Return Strategy Ideas - baoquankhu1.vn
Aug Intraday: How does Lexaria Bioscience Corp correlate with Nasdaq2026 Market Mood & Daily Entry Point Alerts - baoquankhu1.vn
Moving Averages: Will Lexaria Bioscience Corp Equity Warrant stock go up in YEARShare Buyback & Daily Entry Point Alerts - baoquankhu1.vn
Lexaria pursues oral GLP-1 drug delivery partnerships By Investing.com - Investing.com Australia
If You Invested $1,000 in Lexaria Bioscience Corp (LEXX) - Stock Titan
Lexaria Targets Booming GLP-1 Market With Enhanced Oral Drug Platform - TipRanks
Lexaria pursues oral GLP-1 drug delivery partnerships - Investing.com
Lexaria Bioscience Corp.: Lexaria's Oral GLP-1 Drug Strategy Validated by Industry - FinanzNachrichten.de
Lexaria's Oral GLP-1 Drug Strategy Validated by Industry - standard-journal.com
Weight-loss pills over shots? Lexaria says pharma talks are underway - Stock Titan
Aug Decliners: Can Lexaria Bioscience Corp expand into new markets2026 Pullback Review & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Published on: 2026-03-22 08:08:07 - baoquankhu1.vn
Is Lexaria Bioscience Corp exposed to political risk2026 Key Highlights & Intraday High Probability Alerts - baoquankhu1.vn
100,000 Lexaria (LEXX) shares gifted back to the company - Stock Titan
Update Recap: Is Lexaria Bioscience Corp benefiting from interest rate changesPortfolio Return Report & Capital Protection Trade Alerts - baoquankhu1.vn
Volume Recap: Is Lexaria Bioscience Corp a strong candidate for buy and hold2026 Drop Watch & Intraday High Probability Setup Alerts - baoquankhu1.vn
Market Rankings: Can Lexaria Bioscience Corp Equity Warrant sustain earnings growthTrade Risk Assessment & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Lexaria launches 2026 research program for drug delivery tech - Investing.com Nigeria
Buybacks Report: Will Lexaria Bioscience Corp Equity Warrant outperform tech stocksJuly 2025 Sector Moves & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Buybacks Report: Is Lexaria Bioscience Corp Equity Warrant currently under institutional pressureAnalyst Upgrade & Weekly Breakout Stock Alerts - baoquankhu1.vn
Aug Wrap: Can Lexaria Bioscience Corp Equity Warrant sustain earnings growth2025 Market Sentiment & Stock Market Timing Techniques - baoquankhu1.vn
Lexaria Bioscience files to sell 2.76M shares of common stock for holders - MSN
Lexaria launches 2026 research program for drug delivery tech By Investing.com - Investing.com Australia
Lexaria Announces New R&D Plans for 2026 - Investing News Network
Lexaria Launches 2026 R&D Push to Advance GLP-1 and Cannabidiol Drug Delivery - TipRanks
Lexaria Bioscience Corp Announces New Research and Development Program - marketscreener.com
LEXX Initiates 2026 R&D Program to Enhance Pharma Innovations - GuruFocus
Biotech tests new oral GLP-1 formulas against Wegovy tablets - Stock Titan
Update Recap: Will Smith Douglas Homes Corp benefit from rate cuts2025 Big Picture & Long Hold Capital Preservation Plans - baoquankhu1.vn
Is Lexaria Bioscience Corp. exposed to currency risksMarket Performance Recap & Technical Pattern Alert System - mfd.ru
Lexaria Bioscience: Improving Oral Weight-Loss Drug Tolerability - The Globe and Mail
Aug Wrap: Is Lexaria Bioscience Corp a strong candidate for buy and holdEarnings Recap Summary & Weekly High Potential Stock Alerts - baoquankhu1.vn
Lexaria Bioscience: Oral Drug Delivery Technology Targets Next-Gen Weight Loss Market - The Globe and Mail
LEXX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Aug Intraday: Can Lexaria Bioscience Corp expand into new marketsJuly 2025 Movers & Low Risk Growth Stock Ideas - baoquankhu1.vn
US Market Wrap: What are the risks of holding Hanover Bancorp IncMarket Growth Summary & Safe Capital Allocation Plans - baoquankhu1.vn
Update Report: Can Lexaria Bioscience Corp Equity Warrant sustain earnings growth2025 Dividend Review & Low Risk Investment Opportunities - baoquankhu1.vn
Published on: 2026-02-20 23:25:19 - baoquankhu1.vn
Will Lexaria Bioscience Corp. Equity Warrant stock go up in YEARJuly 2025 Selloffs & Entry Point Confirmation Signals - mfd.ru
Published on: 2026-02-20 04:22:15 - baoquankhu1.vn
Aug Intraday: Is Lexaria Bioscience Corp exposed to currency risksJuly 2025 Chart Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Aug Action: Will NHICU outperform tech stocksDip Buying & Verified Short-Term Trading Plans - baoquankhu1.vn
Is Lexaria Bioscience Corp. likely to announce a buyback2025 Support & Resistance & Entry Point Strategy Guides - mfd.ru
How Lexaria Bioscience Corp. Equity Warrant stock performs in interest rate cyclesQuarterly Earnings Summary & AI Optimized Trade Strategies - mfd.ru
Why Lexaria Bioscience Corp. stock could rally in 2025July 2025 Update & Real-Time Market Trend Scan - mfd.ru
Can Lexaria Bioscience Corp. ride the EV wave2025 AllTime Highs & AI Powered Market Entry Strategies - mfd.ru
Will Lexaria Bioscience Corp. stock attract ESG investorsMarket Trend Report & Entry and Exit Point Strategies - mfd.ru
LEXX PE Ratio & Valuation, Is LEXX Overvalued - Intellectia AI
Aug Momentum: Can Lexaria Bioscience Corp. Equity Warrant stock outperform in 2025 bull marketWatch List & AI Optimized Trading Strategy Guides - mfd.ru
Can Lexaria Bioscience Corp. Equity Warrant sustain earnings growthJuly 2025 PostEarnings & Low Risk High Win Rate Stock Picks - mfd.ru
Research Analysts Set Expectations for LEXX Q2 Earnings - Defense World
Lexaria Bioscience Corp (LEXX) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):